Products

Medomics 2021 Novel New Virus Neutralizing Antibody Elisa Test Kit

China Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit, Find details about China Medical, Neutralizing Antibody from Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit

HS Code
3002150090
HS Code
3002150090
The Medomics Neutralizing Antibody Test Kit (ELISA) is suitable for in vitro qualitative detection of neutralizing antibodies in human serum samples.

The Medomics Neutralizing Antibody is an important marker for assessing the effectiveness of the new infectious novel virus Vaccines. This reagent is suitable for neutralizing antibody detection in the samples from individuals with vaccine injection people and recovered people.

The Medomics Neutralizing Antibody Test Kit (ELISA) is of great significance for the development of the infectious novel vaccines, evaluation of effectiveness, and evaluation of neutralizing antibody levels in the population. 

Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test KitMedomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit
Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test KitMedomics 2019 Novel New Virus Neutralizing Antibody Elisa Test KitMedomics 2019 Novel New Virus Neutralizing Antibody Elisa Test KitMedomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit
 
Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit
Key Features:
 
Packing Size:96tests/kit, 96test/kits*2
Specimen type:blood, serum, plasma
Storage:2-8
Shelf Life:24 months
Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit

About Medomics
Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.  

Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.

Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit
Contact Medomics
Medomics 2019 Novel New Virus Neutralizing Antibody Elisa Test Kit

You Might Also Like